Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PM Stock Forecast 2026-2027
$180.19
Current Price
$280.84B
Market Cap
Buy 11
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to PM Price Targets
+16.5%
To High Target of $210.00
+11.0%
To Median Target of $200.00
-5.1%
To Low Target of $171.00
PM Price Momentum
-4.0%
1 Week Change
-2.2%
1 Month Change
-0.3%
1 Year Change
+12.3%
Year-to-Date Change
-6.7%
From 52W High of $193.05
+26.8%
From 52W Low of $142.11
📊 TOP ANALYST CALLS
Did PM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Philip Morris is one of their latest high-conviction picks.
Latest PM Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, PM has a bullish consensus with a median price target of $200.00 (ranging from $171.00 to $210.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $180.19, the median forecast implies a 11.0% upside. This outlook is supported by 11 Buy, 4 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PM Analyst Ratings
11
Buy
4
Hold
0
Sell
PM Price Target Range
Low
$171.00
Average
$200.00
High
$210.00
Current: $180.19
Latest PM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 2, 2026 | UBS | Faham Baig | Neutral | Maintains | $182.00 |
| Jun 3, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Apr 23, 2026 | Needham | Buy | Reiterates | $N/A | |
| Apr 17, 2026 | UBS | Neutral | Maintains | $N/A | |
| Apr 17, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Apr 13, 2026 | Needham | Buy | Maintains | $N/A | |
| Apr 10, 2026 | Stifel | Buy | Maintains | $N/A | |
| Feb 10, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Feb 10, 2026 | Needham | Buy | Maintains | $N/A | |
| Jan 20, 2026 | Jefferies | Hold | Downgrade | $N/A | |
| Nov 26, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Nov 17, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Sep 5, 2025 | UBS | Neutral | Maintains | $N/A | |
| Jul 30, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Jul 23, 2025 | Needham | Buy | Reiterates | $N/A | |
| Jul 14, 2025 | UBS | Neutral | Maintains | $N/A | |
| Jul 10, 2025 | Citigroup | Buy | Maintains | $N/A | |
| Jul 10, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Jul 10, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Jul 9, 2025 | Jefferies | Buy | Initiates | $N/A |
Philip Morris International Inc. (PM) Competitors
The following stocks are similar to Philip Morris based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Philip Morris International Inc. (PM) Financial Data
Philip Morris International Inc. has a market capitalization of $280.84B with a P/E ratio of 25.6x. The company generates $41.49B in trailing twelve-month revenue with a 26.7% profit margin.
Revenue growth is +9.1% quarter-over-quarter, while maintaining an operating margin of +36.0% and return on equity of -141.0%.
Valuation Metrics
Market Cap
$280.84B
Enterprise Value
$331.56B
P/E Ratio
25.6x
PEG Ratio
-2.7x
Price/Sales
6.8x
Growth & Margins
Revenue Growth (YoY)
+9.1%
Gross Margin
+68.1%
Operating Margin
+36.0%
Net Margin
+26.7%
EPS Growth
-9.4%
Financial Health
Cash/Price Ratio
+1.9%
Current Ratio
1.0x
Debt/Equity
-7.1x
ROE
-141.0%
ROA
+15.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Philip Morris International Inc. (PM) Business Model
About Philip Morris International Inc.
What They Do
Produces tobacco and smoke-free products globally.
Business Model
The company generates revenue through a diverse range of tobacco products, including traditional cigarettes and innovative smoke-free alternatives. Its flagship brand, Marlboro, continues to be a strong revenue source, but products like Iqos and Zyn are increasingly important as they drive growth in the reduced-harm segment.
Additional Information
Philip Morris International has a significant focus on research and development, especially for nicotine delivery systems that minimize health risks. The company operates from its headquarters in Lausanne, Switzerland, and has a global reach, selling products in over 180 countries. Following its separation from Altria Group in 2008, it has established itself as a key player in both the combustible and smoke-free tobacco markets.
Company Information
Sector
Consumer Defensive
Industry
Tobacco
Employees
84,900
CEO
Mr. Jacek Olczak
Country
United States
IPO Year
2008
Website
www.pmi.comPhilip Morris International Inc. (PM) Latest News & Analysis
Latest News
Quick Summary
Philip Morris International is set to release its earnings report soon; however, the author expresses a decision not to invest in the company.
Why It Matters
Negative sentiment around Philip Morris International's earnings could signal lower future profitability, impacting stock performance and investor confidence.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Pension funds and major endowments have blacklisted cigarette makers for nearly a decade due to strict sustainability mandates.
Why It Matters
Pension funds and endowments blacklisting cigarette makers signals a shift in investment strategies towards sustainability, potentially impacting stock prices and investment flows in the tobacco sector.
Source: New York Post
Market Sentiment:
Neutral
Tobacco Stocks Are Coming in From the Cold
5 days ago
Quick Summary
Investors are increasingly scrutinizing companies transitioning away from cigarette production.
Why It Matters
A shift away from cigarettes suggests potential growth in alternative products, impacting company valuations and investment strategies in the tobacco sector.
Source: WSJ
Market Sentiment:
Neutral
Quick Summary
Altria retains strong U.S. market share with Marlboro, generating significant free cash flow. Philip Morris is expanding its smoke-free brands, IQOS and ZYN, in over 100 markets globally.
Why It Matters
Altria's strong cash flow supports stability, while Philip Morris's global expansion in smoke-free products signals growth potential, impacting market competition and investment strategies.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
The FDA approved 20 Zyn nicotine pouch products from Philip Morris to carry a modified-risk claim, enhancing their market position as cigarette sales decline.
Why It Matters
The FDA's approval boosts Philip Morris' market position and credibility for Zyn products, potentially increasing sales as cigarette demand drops, impacting overall revenue and stock performance.
Source: CNBC
Market Sentiment:
Positive
Quick Summary
The FDA has permitted Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes, which may impact investor sentiment and market dynamics in the tobacco sector.
Why It Matters
FDA approval for Philip Morris to market Zyn as less harmful may boost sales, reshape nicotine product perceptions, and impact tobacco stock valuations positively.
Source: Reuters
Market Sentiment:
Positive
Frequently Asked Questions About PM Stock
What is Philip Morris International Inc.'s (PM) stock forecast for 2027?
Based on our analysis of 5 Wall Street analysts, Philip Morris International Inc. (PM) has a median price target of $200.00. The highest price target is $210.00 and the lowest is $171.00.
Is PM stock a good investment in 2027?
According to current analyst ratings, PM has 11 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $180.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PM stock?
Wall Street analysts predict PM stock could reach $200.00 in the next 12 months. This represents a 11.0% increase from the current price of $180.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Philip Morris International Inc.'s business model?
The company generates revenue through a diverse range of tobacco products, including traditional cigarettes and innovative smoke-free alternatives. Its flagship brand, Marlboro, continues to be a strong revenue source, but products like Iqos and Zyn are increasingly important as they drive growth in the reduced-harm segment.
What is the highest forecasted price for PM Philip Morris International Inc.?
The highest price target for PM is $210.00 from at , which represents a 16.5% increase from the current price of $180.19.
What is the lowest forecasted price for PM Philip Morris International Inc.?
The lowest price target for PM is $171.00 from at , which represents a -5.1% decrease from the current price of $180.19.
What is the overall PM consensus from analysts for Philip Morris International Inc.?
The overall analyst consensus for PM is bullish. Out of 5 Wall Street analysts, 11 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $200.00.
How accurate are PM stock price projections?
Stock price projections, including those for Philip Morris International Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2026 3:32 AM UTC